Eli Lilly NYSE:LLY, the diabetes and obesity-drug powerhouse, traded at $1,154.24 Thursday as Mounjaro secured a concrete African growth target. Distributor Aspen Pharmacare expects regional sales to break 2 billion rand, or roughly $124 million, in the year ending June 2027.South Africa is already…Read More
Lilly’s African Mounjaro Push Starts at 1.25% of Quarterly Sales
By TradingView
